Listeria Bacteria Found to be Susceptible to Previously Resistant Antibiotic in Lab

by Rishika Gupta on  September 5, 2018 at 10:15 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Fosfomycin antibiotic has been found to be effective in treating listeria in the lab, because the gene that is usually activated by the bacteria after entering the body is absent here. The findings of this study are published in the PLOS Genetics journal.
The food-poisoning bug Listeria was shown to respond to an antibiotic even though the bacteria carry genes that should make it highly resistant.
 Listeria Bacteria Found to be Susceptible to Previously Resistant Antibiotic in Lab
Listeria Bacteria Found to be Susceptible to Previously Resistant Antibiotic in Lab

Scientists say the antibiotic - called fosfomycin - should be reconsidered as a treatment for life-threatening Listeria infections.

Early lab tests had indicated that fosfomycin fails to kill Listeria because the bacteria carry a gene that enables it to break down the drug.

Further studies, however, found that the drug was effective at killing Listeria in infected cells in the lab and in mice.

Genes that are only activated when the bacteria infect the body cancel out the effects of the drug-destroying gene, researchers at the University of Edinburgh found.

The findings suggest fosfomycin could prove to be a useful treatment for life-threatening Listeria cases despite these bacteria testing resistant based on laboratory tests, the researchers say.

Listeria infection - also known as listeriosis - is the most lethal food-borne disease known and is often fatal. It is caused by eating contaminated foods such as soft cheeses, smoked salmon, pates, meats and salads.

The infection is particularly deadly for those with weak immune systems, such as older people and newborns. It can also cause miscarriage.

These bacteria reproduce within the cells of the body and frequently affect the brain, which only certain medicines are able to treat. This limits the treatment options for serious infections, and so fosfomycin may prove highly beneficial.

Professor Jose Vazquez-Boland, who led the research at the University of Edinburgh's Division of Infection Medicine, said: "Our study focused on Listeria, but this important discovery may be relevant for other species of bacteria too. It is encouraging that we may be able to repurpose existing drugs in the race against antibiotic resistance."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Shigellosis MRSA - The Super Bug Drug Resistance - Antibiotic Resistance Food Safety for Health Antibiotics Eye Infections Natural Antibiotics to Fight Bacterial Infections Vancomycin-Resistant Enterococci (VRE) Boils - Treatment by Drugs Multiple Drug Allergy Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive